Comparison of afatinib and erlotinib combined with bevacizumab in untreated stage IIIB/IV epidermal growth factor receptor-mutated lung adenocarcinoma patients: a multicenter clinical analysis study
比较阿法替尼和厄洛替尼联合贝伐单抗治疗未经治疗的IIIB/IV期表皮生长因子受体突变型肺腺癌患者的疗效:一项多中心临床分析研究
期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/17588359221113278
Lee, Suey-Haur; Lin, Yu-Ching; Chiu, Li-Chung; Ju, Jia-Shiuan; Tung, Pi-Hung; Huang, Allen Chung-Cheng; Li, Shih-Hong; Fang, Yueh-Fu; Chen, Chih-Hung; Kuo, Scott Chih-Hsi; Wang, Chin-Chou; Yang, Cheng-Ta; Hsu, Ping-Chih